{"url_path":"/sec/goss/8-k/2026-07-01/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-01","source_url":"https://www.sec.gov/Archives/edgar/data/1728117/0001728117-26-000057-index.html","accession_number":"0001728117-26-000057","cik":"0001728117","ticker":"GOSS","issuer_name":"Gossamer Bio, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1728117/0001728117-26-000057-index.html","primary_entity_key":"0001728117","primary_entity_name":"Gossamer Bio, Inc."},"word_count":83,"has_tables":true,"body_markdown":"Item 9.01 Financial Statements and Exhibits.\n\n(d) Exhibits. \n\nExhibit\nNumber Description\n\n99.1 \n[Press release of Gossamer Bio, Inc.](goss-20260701xexx991xprcon.htm) dated July 1, 2026.\n\n104 Cover page interactive data file (embedded with the inline XBRL document)\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.\n\n \n\n  GOSSAMER BIO, INC.\n\n    \n\nDate: July 1, 2026 By:/s/ Christian Waage\n\n   Christian Waage\n\n   Executive Vice President and General Counsel"}